Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.850
-0.130 (-4.36%)
At close: Apr 7, 2026, 4:00 PM EDT
2.791
-0.059 (-2.08%)
After-hours: Apr 7, 2026, 7:05 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $26.74 million as of April 7, 2026.
Market Cap
26.74M
Enterprise Value
-3.87M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $26.74M, a decrease of -84.34%. That is a compound annual growth rate of -85.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 27.96M | -30.70% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 30.56M |
| BriaCell Therapeutics | 29.39M |
| NeuroSense Therapeutics | 29.34M |
| Hyperion DeFi | 29.19M |
| Kyntra Bio | 28.37M |
| CEL-SCI | 28.08M |
| ABVC BioPharma | 26.93M |
| Exicure | 26.71M |